Wei-Hsuan Jenny Lo-Ciganic, PhD, MSCP, MS, is an assistant professor in the University of Arizona College of Pharmacy, Department of Pharmacy, Practice and Science. She is a pharmcoepidemiologist and biostatistician with interests in medication adherence to essential chronic medications, drug safety, cancer prevention, quality and value of prescribing, and diffusion of new drugs for chronic disease management (e.g., diabetes, hypertension, chronic kidney disease), especially among vulnerable or minority populations (e.g., older adults, pregnant women). Several of her previous projects have focused on evaluating cholesterol-lowering medication use in older adults, associations between statin use and physical function decline in older adults, and associations between non-opioid analgesics and risk of ovarian cancer. She has been involved in the largest population-based case-control study of ovarian cancer in the U.S. (Hormone and Ovarian Cancer Prediction [HOPE] Study) and the Ovarian Cancer Association Consortium (OCAC), which collects individual-level data from 48 case-only or case-control studies worldwide. Methodologically, Dr. Lo-Ciganic is experienced in a wide range of both quantitative and qualitative methods. She has expertise in analyses of administrative healthcare data (e.g., Medicaid claims), supervised machine-learning methods, group-based trajectory models, scale development and psychometrics, and the development and evaluation of an integrated program intervention with a community-based design.
Dr. Lo-Ciganic received her pharmacy degree from National Taiwan University (Taipei, Taiwan) in 2003, and an MS in clinical pharmacy from National Cheng-Kung University (Tainan, Taiwan) in 2005. She also completed an MS in biostatistics at the University of Pittsburgh in 2010 and received her PhD in epidemiology at the University of Pittsburgh in 2013. Prior to arriving at the University of Arizona, she worked as a postdoctoral associate for the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh Health Policy Institute. In that role, she collaborated on a variety of studies focused on application of novel statistical methods for improving medication adherence measures in diabetes and treatment for opioid use disorders. Although her collaborative work at University of Pittsburgh will continue, Dr. Lo-Ciganic looks forward to developing new resources and collaborators at the Department of Pharmacy Practice and Science. Her long-range career objective is to conduct pharmacoepidemiologic/comparative effectiveness/health service research to better understand the patient, provider, health system and regional factors that impact drug utilization to inform clinical medicine, health promotion, and health policy, and ultimately to improve health outcomes and quality. Dr. Lo-Ciganic's primary research interests include the areas of chronic disease management/prevention, drug-related problems and therapeutic risk management/prevention, medication adherence to essential chronic medications, quality and value of prescribing, and diffusion of new drugs for chronic disease management among vulnerable or minority populations. She is also interested in the application of novel methodologies such as classification and regression tree models and group-based trajectory models in pharmacoepidemiology studies.